Amino acid replacement: ?483term.
G6011505A
G?A
W483term | Src42A-PA; W1563term | Src42A-PB
?483term
G to A nucleotide change at the second or third position of the wild type Trp codon leads to a nonsense mutation (exact site of mutation unspecified). The mutation was annotated at the second base of the codon.
In the tracheal dorsal trunk of stage 17 Src42AE1 heterozygoous and homozygous embryos, tanedial folds are similar to controls.
Src42AE1 mutants display occasional wandering/defasciculation in commissural axon pathfinding but remain ipsilateral in the embryonic central nervous system.
Average Citrate Synthase activity is increased by 7% in heterozygous males and by 33% in Src42AKG02515/Src42AE1 transheterozygotes.
Mutant embryos show salivary gland guidance defects; they show ventral curving at the tip and they also show more generalised curving defects.
Some Src42AE1 larvae display a tracheal necrosis phenotype, while others display a superficially normal-looking tracheal tree, where cuticle secretion has been completed. These larvae also show an abnormal taenidial fold pattern.
Src42AE1 embryos show no salivary gland invagination defects.
75.7 +/- 3.6% of homozygotes die as embryos. Homozygous embryos have malformed mouth parts.
Src42Ak10108/Src42AE1 has abnormal neuroanatomy phenotype, enhanceable by Src64Bko
Src42AE1 has abnormal neuroanatomy phenotype, non-enhanceable by Src64Bko
Src42AE1 has abnormal neuroanatomy phenotype, non-suppressible by Src64Bko
Src42AE1, Src42A[+], Src64B[+], Src64BPI is an enhancer of abnormal neuroanatomy | third instar larval stage phenotype of FakK24/FakN30
Src42AE1 is an enhancer of visible phenotype of Hsap\HTT128Q.1-336.UAS, Scer\GAL4GMR.PU
Src42AE1 is an enhancer of partially lethal - majority die phenotype of DAAMEx1
Src42AE1 is a suppressor of increased size | embryonic stage phenotype of empe3d1
PezCB-5380-3, Src42AE1 has abnormal wound healing | embryonic stage phenotype
Src42Ak10108/Src42AE1, Src64B[+]/Src64Bko has abnormal neuroanatomy phenotype
Src42AE1/Src42A[+], Src64BPI has abnormal neuroanatomy | third instar larval stage phenotype
FakN30/FakKG00304, Src42AE1/Src42A[+] has abnormal neuroanatomy | third instar larval stage phenotype
Src42Ak10108/Src42AE1 has fascicle phenotype, enhanceable by Src64Bko
Src42Ak10108/Src42AE1 has symmetrical commissure phenotype, enhanceable by Src64Bko
Src42AE1 has symmetrical commissure phenotype, non-enhanceable by Src64Bko
Src42AE1 has symmetrical commissure phenotype, non-suppressible by Src64Bko
Src42AE1, Src42A[+], Src64B[+], Src64BPI is an enhancer of neuromuscular junction | third instar larval stage phenotype of FakK24/FakN30
Src42AE1 is an enhancer of eye phenotype of Hsap\HTT128Q.1-336.UAS, Scer\GAL4GMR.PU
Src42AE1 is an enhancer of embryonic/larval tracheal section phenotype of DAAMEx1
Src42AE1 is an enhancer of presumptive embryonic salivary gland phenotype of Btkk00206
Src42AE1 is a suppressor of tracheal dorsal trunk primordium | embryonic stage phenotype of empe3d1
Src42AE1/Src42AE1 is a suppressor of taenidial fold | embryonic stage 17 phenotype of Blimp-1KG09531
Src42AE1 is a suppressor of embryonic/larval tracheal section phenotype of DAAMC.UASp, Scer\GAL4btl.PS
Src42Ak10108/Src42AE1, Src64B[+]/Src64Bko has symmetrical commissure phenotype
Src42Ak10108/Src42AE1, Src64B[+]/Src64Bko has fascicle phenotype
Src42AE1, p130CAS1 has embryonic head phenotype
Src42AE1, p130CAS1 has embryo | late embryonic stage phenotype
Src42AE1, p130CAS1 has larva | first instar larval stage phenotype
Src42AE1/Src42A[+], Src64BPI has neuromuscular junction | third instar larval stage phenotype
FakN30/FakKG00304, Src42AE1/Src42A[+] has neuromuscular junction | third instar larval stage phenotype
FakN30/FakKG00304, Src42AE1/Src42A[+] has NMJ bouton | increased number | third instar larval stage phenotype
Src42AE1/Src42Ak10108 ; Src64Bko/+ mutants display occasional wandering/defasciculation in commissural axon pathfinding but remain ipsilateral in the embryonic central nervous system.
Src42AE1/Src42Ak10108 ; Src64Bko/Src64Bko double mutants exhibit severe defects in Fas2-positive axons, with Fas2-positive ipsilateral axons often crossing the midline inappropriately. eg-positive commissural neurons do not exhibit defects in these mutants.
Src42AE1+; Src64Bko mutants display occasional wandering/defasciculation in commissural axon pathfinding but remain ipsilateral in the embryonic central nervous system.
Significant overgrowth of the neuromuscular junction (NMJ) (increased bouton number per muscle area and increased NMJ length per muscle area) is seen in Src42AE1/+ FakN30/FakKG00304 third instar larvae.
Significant overgrowth of the NMJ (increased bouton number per muscle area) is seen in Src42AE1/+ ; Src64BPI/Src64BPI third instar larvae.
The overgrowth at the NMJ (increased bouton number per muscle area) seen in FakN30/FakK24 third instar larvae is enhanced if they are also carrying both Src42AE1/+ and Src64BPI/+.
The cuticle and semi-lethal phenotypes of DAAMEx1 larvae is enhanced by Src42AE1.
The tracheal cuticle defects of larvae that express DAAMC.Scer\UAS.P\T under the control of Scer\GAL4btl.PS are dominantly suppressed by Src42AE1.
Btk29Ak00206; Src42AE1 embryos show an enhanced salivary gland invagination phenotype compared to Btk29Ak00206 single mutants. More salivary glands show premature endoreplication in the double mutants. The double mutants also show the disorganised actin phenotype although it is not clear whether this is enhanced compared to Btk29Ak00206 embryos.